Roquefort Therapeutics (LON:ROQ) Shares Up 0.4% – Here’s What Happened

Roquefort Therapeutics plc (LON:ROQ)’s stock price was up 0.4% on Monday . The stock traded as high as GBX 3.99 ($0.05) and last traded at GBX 3.99 ($0.05). Approximately 17,350 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 516,817 shares. The stock had previously closed at GBX 3.97 ($0.05).

Roquefort Therapeutics Stock Performance

The company has a debt-to-equity ratio of 12.37, a current ratio of 0.79 and a quick ratio of 3.07. The stock has a market cap of £5.15 million, a P/E ratio of -397.00 and a beta of 0.05. The stock has a 50-day simple moving average of GBX 3.99 and a 200-day simple moving average of GBX 4.26.

About Roquefort Therapeutics

Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action.